Erectile dysfunction in patients of diabetes mellitus: a cross sectional study (original) (raw)
Related papers
Prevalence of erectile dysfunction in diabetic patients
Current Medicine Research and Practice, 2018
Introduction: Erectile dysfunction (ED) is one of the most common yet neglected medical problems which warrants screening at regular interval so that appropriate treatment can be delivered. The aim of this study was to determine the prevalence of erectile dysfunction in Type 2 diabetic men. Material and methods: The study was conducted in Department of Medicine at Sir Ganga Ram hospital, New Delhi. All males diagnosed with type 2 Diabetes Mellitus between age group of 18-65, were included in the study. Non Diabetic males of same age group were also taken as control group. SHIM questionnaire was administered to all patients and controls. Association of ED with duration of diabetes (<5 yrs., 5-10 yrs., >10 yrs.) were compared. Results: Prevalence of ED determined by SHIM score was 78.7% which is more than in the control group (46%). ED was significantly more in diabetic population than in non-diabetics. In present study, 21.4% of the diabetic males had No ED, 12.3% had mild ED, 30.9% had mild to moderate ED, 19.1% had moderate ED and 16.4% had severe ED. Longer duration of diabetes consistently increased the risk of ED. Duration of diabetes had a significant correlation with ED. Conclusion: Prevalence of ED in was significantly more in diabetic population than in non-diabetics.
Risk Factors for Erectile Dysfunction in Patients with Newly Diagnosed Diabetes Mellitus
Medical Archives, 2010
2 g oal: To evaluate risk factors of erective dysfunction (ED) and find out incidence in patients with newly diagnosed diabetes mellitus. Material and methods: All patients from Centre for Diabetes with newly diagnosed diabetes mellitus type 2 are involved in study. We have done interview using questionnaire-International Index of Erectile Function (IIEF)-5. Result of IIEF-5 less than 21 was used as bottom line for identification of patients with ED. Results: newly diagnosed diabetes mellitus type 2 was a case in 243 patients from which 37% of them had ED. Comparing potent man with those with ED there are statistically significant difference according to smoking, duration of smoking, hypertension, body mass index and serum level of glycozated hemoglobin HbA1c. Using multivariate logistic regression model, age was identified as the most significant risk factor. Conclusion: Patients with newly diagnosed diabetes mellitus have high prevalence of ED which can be related with other risk factors such as age of diabetes onset, hypertension, smoking and body mass index.
Advances in Endocrinology, 2016
Background. The frequency of erectile dysfunction (ED) complicating diabetes mellitus (DM) is reportedly high. However, its risk factors have not been well studied. Methods. This was a cross-sectional study of 160 male type 2 DM adults, aged 30–70 years, attending a tertiary healthcare clinic. Demographic and relevant clinical information was documented. Erectile function was assessed using an abridged version of the International Index of Erectile Function (IIEF-5). All subjects were evaluated for central obesity, glycemic control, peripheral arterial disease (PAD), autonomic neuropathy, dyslipidemia, and testosterone deficiency. Results. 152 (95%) patients with a mean age of 60.3 ± 8.8 years completed the study. 71.1% had varying degrees of ED, while 58.3% suffered from a moderate-to-severe form. Independent predictors of ED [presented as adjusted odds ratio (95% confidence interval)] were longer duration of DM, 1.14 (1.02–1.28), PAD, 3.87 (1.28–11.67), autonomic neuropathy, 3.51 ...
Erectile dysfunction and diabetes mellitus
Insulin, 2009
Erectile dysfunction (ED), defined as the persistent inability to achieve and maintain an erection for successful intercourse, is a major sexual concern for many men. 1 Risk factors for ED include cardiovascular disease, diabetes mellitus (DM), hyperlipidemia, smoking, and obesity. 2,3 ED is associated with depression and has a profound negative impact on the quality of life of patients and their partners. 4 The prevalence of ED is higher in men with DM than in those without DM (age-adjusted relative risk [RR], 1.32; 95% CI, 1.3-1.4). The pathophysiology of ED is multifactorial, and men with DM are one of the most difficultto-treat subgroups of patients with ED. The aim of this review was to provide an overview of the epidemiology and underlying pathophysiology of ED in men with DM, diagnostic modalities, and treatment options.
Experiences of male patients with diabetes mellitus with erectile dysfunction
International journal of health sciences
Diabetes mellitus (DM) is a disease or chronic metabolic disorder with multiple etiologies characterized by high blood sugar levels and impaired carbohydrate, lipid, and protein metabolism resulting from insulin function insufficiency. Various complications occur in DM patients, one of which is erectile dysfunction. In men with the same age profile, erectile dysfunction is more common than in non-diabetics. To determine the experience of male patients with diabetes mellitus who suffer erectile dysfunction. Journal search with literature review system using diabetes mellitus and erectile dysfunction. PICO framework as a strategy in article search. The investigation was carried out on PubMed, Scopus, Ebsco, ProQuest, and Science Direct websites. Journal reviews were carried out on four articles, and the research results with article inclusion criteria ranged from 2015-to 2021. The research design used an observational with a cross-sectional approach. The initial search resulted in 329...
Erectile dysfunction and diabetes: a study in primary care
The British Journal of Diabetes & Vascular Disease, 2004
T his study set out to determine whether there has been an increase in awareness of ED amongst men with diabetes following the introduction of oral therapy and whether there is an association between ED and QoL. Current perceptions of 157 men with diabetes were compared with the results of a 1997 survey. Those who reported ED (66/157) completed a questionnaire assessing the impact of ED on QoL. Patients are more aware of ED now than in 1997; more treatments are now offered in primary care. The results demonstrated a weak, but significant, association between awareness of therapy (represented by the number of treatments of which patients were aware) and QoL. Patients who were aware of treatments had a significantly worse QoL than those who were unaware. Br J Diabetes Vasc Dis 2004;6:387-92